2022 FDA approvals

Nat Rev Drug Discov. 2023 Feb;22(2):83-88. doi: 10.1038/d41573-023-00001-3.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents*
  • Drug Approval
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents